Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece

por Gourzoulidis, George, Zisimopoulou, Oresteia, Boubouchairopoulou, Nadia, Michailidi, Christina, Lowry, Chrissy, Tzanetakos, Charalampos, Kourlaba, Georgia
Publicado 2022